Developing the Next Generation of Targeted, Conditionally Active Cytokine Therapeutics Mar 30, 2023 Blog
Founder & CEO John Mulligan Shares Bonum Therapeutics’ “No Jerks” Approach to Hiring Feb 14, 2023 Blog